MedChunk
Medically reviewed

What Causes Alzheimer's Disease? Triggers and Treatment

Alzheimer's disease is linked to gradual changes involving amyloid and tau proteins in the brain. Learn about its causes, risk factors, possible triggers, and available treatments.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 13 min read

Alzheimer's disease develops when abnormal proteins build up in the brain, damaging nerve cells and affecting memory and thinking. The exact reason this process begins is not fully understood, but aging, inherited genes, health conditions, and lifestyle factors may all influence a person's risk. Although there is currently no cure, several treatments can help manage symptoms, and some newer medicines may slow the disease in selected people.

What happens in the brain to cause Alzheimer's disease?

Alzheimer's disease is associated with the abnormal buildup of two proteins called beta-amyloid and tau. These proteins normally have roles in the brain, but changes in their structure or behavior can interfere with how brain cells work.

Beta-amyloid can collect outside brain cells and form deposits called amyloid plaques. Tau proteins can change shape and form twisted structures called neurofibrillary tangles inside nerve cells. These changes interfere with communication between brain cells and the movement of essential materials within them. Over time, affected cells become damaged and die, and parts of the brain may shrink.

According to the NHS, this protein buildup begins many years before noticeable symptoms appear. However, scientists do not yet know exactly what starts the process or why it develops in some people but not others.

Which factors increase the risk of Alzheimer's disease?

Alzheimer's disease does not have one confirmed cause that applies to everyone. Researchers believe that several factors may work together over time. Having one or more risk factors does not mean that a person will definitely develop the disease.

1. Increasing age

Age is the strongest known risk factor for Alzheimer's disease. The condition most commonly affects people over 65, and the likelihood of developing it increases with advancing age. However, Alzheimer's is not a normal or inevitable part of getting older.

People younger than 65 can also develop the condition. This is known as early-onset or young-onset Alzheimer's disease. Although less common, it can affect people during middle age.

2. Family history and inherited genes

Having a parent, brother, or sister with Alzheimer's disease can increase a person's risk. However, most people who develop the condition do not have a clear family history of it.

One gene associated with increased risk is APOE. A particular form, called APOE-e4, is linked to a greater chance of developing Alzheimer's disease. However, carrying this gene does not mean that someone will definitely develop the condition.

Rare inherited forms are associated with specific genetic changes that can make Alzheimer's disease highly likely to develop, sometimes at a younger age. These cases account for a very small proportion of all Alzheimer's cases. According to Mayo Clinic, age, family history, and genetic factors are among the important risk factors, but they do not explain every case.

3. Heart and blood vessel conditions

Conditions that affect blood vessels and circulation may also be linked to a higher risk of dementia, including Alzheimer's disease. The brain depends on a steady blood supply to receive oxygen and nutrients, so maintaining cardiovascular health is important.

Health conditions and lifestyle factors associated with increased risk include:

  • High blood pressure, particularly when it is not well controlled.
  • Type 2 diabetes, especially when blood sugar remains poorly managed.
  • High cholesterol.
  • Obesity and excess weight.
  • Smoking or regular exposure to tobacco smoke.
  • Low levels of physical activity.
  • Heavy or long-term excessive alcohol use.

These factors are associated with a higher risk of dementia, but they should not be treated as direct or certain causes of Alzheimer's disease. The relationship may involve several processes, including changes in blood vessels and general brain health.

4. Previous head injuries

A serious traumatic brain injury may increase the risk of developing Alzheimer's disease or other forms of dementia later in life. Research has also raised concerns about repeated head injuries. However, most people who experience a head injury do not automatically develop Alzheimer's disease.

5. Hearing loss and other health-related factors

Hearing loss has been associated with a greater risk of dementia. Researchers are still studying the reasons for this relationship, including possible effects on communication, social involvement, and brain activity.

Other factors, such as untreated depression and limited social engagement, have also been linked to dementia risk. These associations do not establish that any one of these factors directly causes Alzheimer's disease.

Are there specific triggers that start Alzheimer's disease?

There is currently no single confirmed trigger that explains when or why Alzheimer's disease begins. Unlike an infection caused by a particular germ, Alzheimer's does not have one identified external cause that can be traced to a specific event.

The disease process may develop gradually over many years. A combination of genetic susceptibility, aging, changes in brain proteins, environmental influences, and general health may contribute to its development.

Some factors, such as a serious head injury or poorly controlled cardiovascular conditions, may influence long-term risk. However, having one of these experiences does not mean that Alzheimer's disease will occur.

Can lifestyle changes reduce the risk of Alzheimer's disease?

Not all risk factors can be changed. Age and inherited genetic factors, for example, are outside a person's control. However, taking care of overall health may help support brain health and reduce some factors associated with dementia.

The Centers for Disease Control and Prevention (CDC) identifies several health habits that may help reduce dementia risk:

  • Stay physically active: Regular movement supports cardiovascular health and general well-being.
  • Manage blood pressure: Keep blood pressure under control through appropriate medical care and healthy habits.
  • Control diabetes: Follow an appropriate treatment plan to manage blood sugar levels.
  • Address hearing problems: Arrange a hearing assessment and discuss suitable treatment when needed.
  • Avoid smoking: Stopping smoking supports blood vessel health and reduces other health risks.
  • Limit excessive alcohol consumption: Avoiding heavy alcohol use may reduce some risks associated with brain damage and dementia.

Eating a balanced diet, maintaining social connections, getting adequate sleep, and keeping the mind active are also reasonable ways to support general health. These measures cannot guarantee that Alzheimer's disease will be prevented, and they are not a treatment for someone who already has the condition.

How is Alzheimer's disease diagnosed before treatment?

Before choosing treatment, healthcare professionals assess whether the changes in memory or thinking are related to Alzheimer's disease or another condition. Memory problems can have several causes, including medication effects and other medical or mental health conditions.

An assessment may include:

  • A review of medical history, current health conditions, and medications.
  • Questions about changes in memory, behavior, language, and everyday activities.
  • Tests of memory, attention, thinking, and problem-solving skills.
  • Medical examinations and tests to check for other possible explanations.
  • Brain imaging or additional investigations when clinically appropriate.

MedlinePlus, a health information service of the US National Library of Medicine, explains that healthcare professionals may review medications, assess thinking abilities, and investigate other medical or mental health conditions when evaluating possible Alzheimer's disease.

In some cases, additional tests may look for biological signs of Alzheimer's, including abnormal amyloid buildup. Confirming the diagnosis and assessing the stage of the disease help determine which treatments may be appropriate.

What treatments are available for Alzheimer's disease?

There is currently no treatment that completely cures Alzheimer's disease or restores all the brain cells that have been damaged. However, medicines, supportive therapies, and practical changes can help manage symptoms, maintain daily function, and support quality of life. Certain newer medicines may also slow the rate of decline in carefully selected people with early-stage disease.

1. Medicines that help manage symptoms

Some medicines affect the chemical messengers that help brain cells communicate. They may improve or temporarily stabilize aspects of memory, thinking, or everyday functioning.

Cholinesterase inhibitors include:

  • Donepezil: Used to manage symptoms across different stages of Alzheimer's disease.
  • Galantamine: Generally used for mild to moderate Alzheimer's disease.
  • Rivastigmine: Used for Alzheimer's symptoms and available in tablet or patch forms.

These medicines work by reducing the breakdown of acetylcholine, a chemical messenger involved in memory and communication between nerve cells. They may help some people maintain their abilities for a period of time, but they do not stop the underlying disease process.

Possible side effects include nausea, vomiting, diarrhea, reduced appetite, and weight loss. The choice of medicine depends on the person's health, symptoms, and tolerance.

Memantine is another medicine used for moderate to severe Alzheimer's disease. It works by regulating the activity of glutamate, a chemical messenger involved in learning and memory. In some cases, it may be prescribed alongside another Alzheimer's medicine.

The NHS treatment guidance describes these medicines as options that may temporarily improve or reduce some symptoms. The benefits and possible side effects should be reviewed with the prescribing healthcare professional.

2. Newer medicines that target amyloid proteins

Some newer treatments are designed to target beta-amyloid, the protein involved in the formation of plaques in the brain. These medicines are known as anti-amyloid treatments or disease-modifying therapies.

Two examples approved by the US Food and Drug Administration (FDA) for selected people with early Alzheimer's disease are:

  • Lecanemab (Leqembi): An antibody treatment that targets beta-amyloid and helps reduce amyloid buildup in the brain.
  • Donanemab (Kisunla): Another antibody treatment that targets amyloid deposits and may slow cognitive and functional decline.

These medicines are intended for people in the early stages of Alzheimer's disease, including certain individuals with mild cognitive impairment or mild dementia due to Alzheimer's. Testing must confirm the presence of elevated amyloid in the brain before treatment is considered.

Clinical trials have shown that these treatments can slow the rate of cognitive decline in eligible patients, but they do not cure Alzheimer's or stop its progression completely. They also have important risks. One is amyloid-related imaging abnormalities (ARIA), which can involve swelling or bleeding in the brain. These changes may sometimes occur without noticeable symptoms but can also become serious.

For this reason, treatment requires specialist assessment and ongoing monitoring. The doctor considers the potential benefits, medical history, treatment risks, and the need for appropriate brain imaging. As explained by the Alzheimer's Association, eligibility for these medicines depends on the stage of disease and confirmation of amyloid buildup.

These are US FDA-approved treatments. Regulatory approval, access, and prescribing requirements may differ in other countries, so availability should be discussed with a local specialist.

3. Supportive therapies and everyday care

Medicines are only one part of Alzheimer's treatment. Supportive approaches can help people maintain independence and participate in daily activities for as long as possible.

  • Cognitive stimulation therapy: Structured group activities may help support memory, communication, and problem-solving skills.
  • Cognitive rehabilitation: A trained professional can help someone work toward practical goals, such as using a phone or managing a familiar daily task.
  • Daily routines: Keeping regular times for meals, activities, and sleep may make everyday life easier to manage.
  • Home adjustments: Clear labels, familiar objects, good lighting, and safer household arrangements may help reduce confusion and accidents.
  • Caregiver support: Education, practical assistance, and emotional support can help family members manage changing care needs.

Changes in behavior, sleep, or mood may also need attention. Doctors may first consider environmental adjustments and other non-drug approaches before prescribing additional medicines for these problems.

When should someone seek medical advice?

Persistent changes in memory, thinking, communication, or everyday functioning should be discussed with a healthcare professional, particularly when they gradually worsen or interfere with familiar activities. An assessment is also important when symptoms appear before age 65, because younger-onset Alzheimer's and other possible causes of cognitive changes may need consideration.

Sudden confusion or an abrupt change in mental functioning is different from the gradual progression typically associated with Alzheimer's disease. Such a change needs prompt medical assessment because it may be related to an acute illness or another problem requiring treatment.

Early evaluation can help identify the cause of the changes, clarify available treatment options, and give the person and family more time to plan appropriate care.

Frequently Asked Questions

Common questions about the causes, risk factors, and treatment of Alzheimer's disease.

What is the main cause of Alzheimer's disease?

Alzheimer's disease is associated with the abnormal buildup of beta-amyloid plaques and tau tangles in the brain. These changes damage nerve cells over time. The exact reason the process begins is not fully understood, and several genetic, health, lifestyle, and environmental factors may influence a person's risk.

Can Alzheimer's disease be inherited from parents?

Having a parent or sibling with Alzheimer's disease can increase a person's risk, but most cases are not caused by a single inherited gene. Rare genetic changes can cause inherited forms of the disease, which may develop at a younger age.

Can stress or poor lifestyle habits trigger Alzheimer's disease?

No single stressful event or lifestyle habit has been established as a direct trigger of Alzheimer's disease. However, factors such as smoking, physical inactivity, poorly controlled diabetes, and high blood pressure are associated with an increased risk of dementia. Managing these factors may support brain health.

Can Alzheimer's disease be prevented completely?

There is no guaranteed way to prevent Alzheimer's disease. Regular physical activity, managing blood pressure and diabetes, avoiding smoking, eating a balanced diet, and addressing hearing problems may help reduce certain risk factors. These measures cannot eliminate the possibility of developing the disease.

Which medicines can slow the progression of Alzheimer's disease?

Lecanemab and donanemab are anti-amyloid treatments that may slow cognitive and functional decline in selected people with early Alzheimer's disease. Other medicines, including donepezil, galantamine, rivastigmine, and memantine, are used mainly to manage symptoms. Treatment suitability depends on the disease stage, test results, medical history, and potential risks.

Citations

  1. NHS – Alzheimer's Disease: Causes
  2. Mayo Clinic – Alzheimer's Disease: Symptoms and Causes
  3. Centers for Disease Control and Prevention – Reducing Risk for Dementia
  4. MedlinePlus – Alzheimer's Disease
  5. NHS – Alzheimer's Disease: Treatment
  6. Alzheimer's Association – Treatments and Research
Share this article